I have a strong passion for molecular biology and their potential application to clinical research. I have gained expertise in applying several ‘Omic’ technologies by studying human and pathogenic eukaryotic cells. So far, I have applied lipidomic, proteomic, metabolomic, transcriptomic, and translatomic for deciphering phenotype-associated biopatterns and modulators. More recently, I have employed CRISPR-Cas technology for gene editing as a strategy to functionally validate phenotype-associated drivers. At this point in time, I am seeking to apply my capacity to combine self-learning, basic laboratory techniques, statistical, and bioinformatic analyses to basic and applied research. I am particularly interested in projects addressed to improve the diagnosis, treatment, and understanding of important human infectious diseases.